Literature DB >> 7652168

Carboplatin enhances the production and persistence of radiation-induced DNA single-strand breaks.

L X Yang1, E B Douple, J A O'Hara, H J Wang.   

Abstract

Fluorometric analysis of DNA unwinding and alkaline elution were used to investigate the production and persistence of DNA single-strand breaks (SSBs) in Chinese hamster V79 and xrs-5 cells treated with the chemotherapeutic agent carboplatin in combination with radiation. Carboplatin was administered to cells before irradiation in hypoxic conditions, or the drug was added immediately after irradiation during the postirradiation recovery period in air. The results of DNA unwinding studies suggest that carboplatin enhances the production of radiation-induced SSBs in hypoxic V79 cells and xrs-5 cells by a factor of 1.86 and 1.83, respectively, when combined with radiation compared to the SSBs produced by irradiation alone. Carboplatin alone did not produce a measurable number of SSBs. Alkaline elution profiles also indicated that the rate of elution of SSBs was higher in cells treated with the carboplatin-radiation combination in hypoxia when compared to irradiation alone, resulting in an increased yield of radiation-induced SSBs by a factor of 1.46 in V79 cells with 20 Gy irradiation and by a factor of 2.02 in xrs-5 cells with 20 Gy irradiation. When carboplatin is present after irradiation and during the postirradiation recovery period, the rejoining of radiation-induced SSBs is inhibited during this postirradiation incubation period (radiopotentiation) with a relative inhibition factor at 1 h postirradiation of 1.25 in V79 cells and 1.15 in xrs-5 cells. An increased production and persistence of SSBs resulting from the interaction of carboplatin with radiation may be an important step in the mechanism responsible for the potentiated cell killing reported previously from studies in animal tumors and in cultured cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7652168

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  9 in total

1.  Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.

Authors:  Regina I Jakacki; Peter C Burger; Tianni Zhou; Emiko J Holmes; Mehmet Kocak; Arzu Onar; Joel Goldwein; Minesh Mehta; Roger J Packer; Nancy Tarbell; Charles Fitz; Gilbert Vezina; Joanne Hilden; Ian F Pollack
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study.

Authors:  Najat C Daw; Yueh-Yun Chi; John A Kalapurakal; Yeonil Kim; Fredric A Hoffer; James I Geller; Elizabeth J Perlman; Peter F Ehrlich; Elizabeth A Mullen; Anne B Warwick; Paul E Grundy; Arnold C Paulino; Eric Gratias; Deborah Ward; James R Anderson; Geetika Khanna; Brett Tornwall; Conrad V Fernandez; Jeffrey S Dome
Journal:  J Clin Oncol       Date:  2020-03-05       Impact factor: 44.544

3.  Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group.

Authors:  Regina I Jakacki; Peter C Burger; Mehmet Kocak; James M Boyett; Joel Goldwein; Minesh Mehta; Roger J Packer; Nancy J Tarbell; Ian F Pollack
Journal:  Pediatr Blood Cancer       Date:  2015-02-19       Impact factor: 3.167

4.  Daily low-dose carboplatin as a radiation sensitizer for newly diagnosed malignant glioma.

Authors:  K Peterson; G Harsh; P G Fisher; J Adler; Q Le
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

5.  Revisiting the BRCA-pathway through the lens of replication gap suppression: "Gaps determine therapy response in BRCA mutant cancer".

Authors:  Sharon B Cantor
Journal:  DNA Repair (Amst)       Date:  2021-08-13

6.  Radiosensitizing effect of carboplatin and paclitaxel to carbon-ion beam irradiation in the non-small-cell lung cancer cell line H460.

Authors:  Nobuteru Kubo; Shin-ei Noda; Akihisa Takahashi; Yukari Yoshida; Takahiro Oike; Kazutoshi Murata; Atsushi Musha; Yoshiyuki Suzuki; Tatsuya Ohno; Takeo Takahashi; Takashi Nakano
Journal:  J Radiat Res       Date:  2015-01-18       Impact factor: 2.724

7.  Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro.

Authors:  Paweł Uruski; Agnieszka Sepetowska; Corinna Konieczna; Martyna Pakuła; Michał Wyrwa; Akylbek Tussupkaliyev; Andrzej Tykarski; Justyna Mikuła-Pietrasik; Krzysztof Książek
Journal:  Cell Mol Biol Lett       Date:  2021-10-21       Impact factor: 5.787

Review 8.  The dogma of Cetuximab and Radiotherapy in head and neck cancer - A dawn to dusk journey.

Authors:  Sapna Krishnamurthy; Imtiaz Ahmed; Rohan Bhise; Bidhu K Mohanti; Atul Sharma; Thorsten Rieckmann; Claire Paterson; Pierluigi Bonomo
Journal:  Clin Transl Radiat Oncol       Date:  2022-03-23

9.  Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma.

Authors:  Satoshi Osawa; Takahisa Furuta; Ken Sugimoto; Takashi Kosugi; Tomohiro Terai; Mihoko Yamade; Yasuhiro Takayanagi; Masafumi Nishino; Yasushi Hamaya; Chise Kodaira; Takanori Yamada; Moriya Iwaizumi; Kosuke Takagaki; Ken-ichi Yoshida; Shigeru Kanaoka; Mutsuhiro Ikuma
Journal:  BMC Cancer       Date:  2009-11-22       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.